Dr. Xu counsels start-up and later-stage biotechnology companies in patent prosecution, patentability analysis, and freedom-to-operate analysis. She has experience in managing patent portfolios and developing domestic and foreign patent prosecution strategies. Dr. Xu also conducts intellectual property due diligence for public offering and merger and acquisition transactions.
Dr. Xu’s technical expertise lies in the areas of immuno-oncology, gene therapy, and antibody development. She has also prosecuted patent applications in treatments for cardiovascular diseases, diagnostic methods, and medical devices.
Dr. Xu is a member of the Boston Patent Law Association.
Prior to joining Goodwin, Dr. Xu was a patent agent in the Boston Office of Lathrop Gage LLP.